Abstract.
Introduction

45
Colorectal carcinoma (CRC) has been reported to be the second deadliest cancer [1] [2] [3] [4] .
46
Although the overall morbidity and mortality of CRC has decreased in recent decades,
47
there has been a considerable increase in patients <50 years of age [4] [5] [6] . Additionally,
48
the 5-year survival of CRC is only 14% as the tumor is often not completely 49 resectable 5, 6 . Despite advances in therapeutic strategies and diagnostic approaches, 
57
AF15q14, a human gene on chromosome 15, was also identical to the D40 gene 8 .
58
Furthermore, D40 expression has been reported to be associated with the pathological 59 features of primary lung tumors, such as degree of differentiation, and patients' 
Results
193
Compared with normal adjacent tissues, the expression of KNL1 was obviously 194 higher in colorectal tumor tissues.
195
RT-qPCR and Western blot were used to measure the expression levels of KNL1 in
196
CRC and para-cancerous tissues. The results revealed that, compared with normal 197 colorectal tissues, KNL1 mRNA and protein levels were much higher in CRC tissues
198
( Fig. 1A and B) . successfully transfected with either an shCtrl or an shKNL1 lentivirus ( Fig. 3A and D) .
210
RT-qPCR was performed 5 days after transfection and KNL1 mRNA expression in the 211 shKNL1 group was much lower compared with in shCtrl-infected control cells (Fig.
212
3B and E). These results were confirmed using western blotting, and it was clear that 213 shKNL1-transfected cells had largely reduced KNL1 levels, indicating that the target 214 gene was successfully knocked down ( Fig. 3C and F) .
216
The CRC cell proliferation is inhibited by KNL1 knockdown. The formation of CRC cell colonies is inhibited by the KNL1 knockdown.
226
RKO and HT-29 cells were stained with crystal violet to assess colony formation ( 
233
The apoptotic rate of RKO cells in the shKNL1 group was 14.86±0.30%, whereas it 234 was 4.32±0.13% in the shCtrl group. The results suggest that apoptosis was 235 significantly increased in the shCtrl group compared with the shNKL1 group (P<0.05)
236
( Fig. 5E and F) . The morbidity and mortality rate of CRC has risen rapidly, and it has attracted 240 worldwide attention 25, 26 . Despite improvements in clinical practice and treatment, 241 outcomes to CRC patients are still poor due to metastasis or drug resistance 27, 28 .
242
Therefore, it is necessary to determine new therapeutic targets and to better 243 understand the underlying molecular mechanism.
244
The occurrence and development of tumors are associated with both behavioral 
257
However, to the best of our knowledge, there have not previously been specific 258 studies regarding KNL1 expression in human cancers, particularly CRC.
259
The results of the present study suggest an obvious relationship between KNL1
260
and CRC cell apoptosis and proliferation. Although many studies described the information regarding the study participants.
267
In conclusion, the results of the present study suggest that shRNA downregulates Not applicable.
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